Latest News for: zolmitriptan

Edit

PassPort Technologies, Inc. Announces Positive Interim Phase I Results of Zolmitriptan Transdermal Microporation System for the Treatment of Acute Migraine

PR Newswire 29 Mar 2024
Zolmitriptan is an FDA-approved prescription medication used for treating migraine symptoms ... Zolmitriptan PassPort® demonstrated tolerability and rapid delivery of zolmitriptan ... Zolmitriptan PassPort® was well-tolerated with no serious adverse events.
Edit

PassPort Technologies, Inc. Initiated US Phase I Clinical Trial of Zolmitriptan Transdermal Microporation System for ...

Longview News-Journal 23 Feb 2024
(PPTI), based in San Diego, initiated a US Phase 1 clinical study of Zolmitriptan PassPort� utilizing its proprietary transdermal microporation system, PassPort� platform technology ... Zolmitriptan, ...
Edit

PassPort Technologies, Inc. Initiated US Phase I Clinical Trial of Zolmitriptan Transdermal Microporation System for the Treatment of Acute Migraine

PR Newswire 23 Feb 2024
(PPTI), based in San Diego, initiated a US Phase 1 clinical study of Zolmitriptan PassPort® utilizing its proprietary transdermal microporation system, PassPort® platform technology ... Zolmitriptan, ...
Edit

Zolmitriptan Nasal Spray Market Size And Forecast To 2030 | 94 Pages Report

MENA FN 17 Oct 2023
(MENAFN - The Express Wire) Worldwide " Zolmitriptan Nasal Spray Market " Research Report 2023 is spread across 94+ Pages and gives important information on Size, Share, Trends, and ... .
  • 1

Most Viewed

×